Effettuare il login Iscriviti gratis

Albireo Pharma Inc Quick ratio

Cos'è Quick ratio di Albireo Pharma Inc?

Quick ratio di Albireo Pharma Inc è 6.23

Qual è la definizione di Quick ratio?



Rapporto rapido è il rapporto di liquidità che misura la capacità di un'azienda di utilizzare i suoi assets rapidi per soddisfare immediatamente le sue obbligazioni a breve termine.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio di aziende nel Health Care settore su NASDAQ rispetto a Albireo Pharma Inc

Cosa fa Albireo Pharma Inc?

Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.

Aziende con quick ratio simili a Albireo Pharma Inc